Literature DB >> 10506747

Arf proteins bind to mitotic kinesin-like protein 1 (MKLP1) in a GTP-dependent fashion.

A L Boman1, J Kuai, X Zhu, J Chen, R Kuriyama, R A Kahn.   

Abstract

Arf proteins comprise a family of 21-kDa GTP-binding proteins with many proposed functions in mammalian cells, including the regulation of several steps of membrane transport, maintenance of organelle integrity, and activation of phospholipase D. We performed a yeast two-hybrid screen of human cDNA libraries using a dominant activating allele, [Q71L], of human Arf3 as bait. Eleven independent isolates contained plasmids encoding the C-terminal tail of mitotic kinesin-like protein-1 (MKLP1). Further deletion mapping allowed the identification of an 88 amino acid Arf3 binding domain in the C-terminus of MKLP1. This domain has no clear homology to other Arf binding proteins or to other proteins in the protein databases. The C-terminal domain of MKLP1 was expressed and purified from bacteria as a GST fusion protein and shown to bind Arf3 in a GTP-dependent fashion. A screen for mutations in Arf3 that specifically lost the ability to bind MKLP1 identified 10 of 14 point mutations in the GTP-sensitive switch I or switch II regions of Arf3. Two-hybrid assays of the C-terminal domain of MKLP1 with each of the human Arf isoforms revealed strong interaction with each. Taken together, these data are all supportive of the conclusion that activated Arf proteins bind to the C-terminal "tail" domain of MKLP1. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10506747     DOI: 10.1002/(SICI)1097-0169(199910)44:2<119::AID-CM4>3.0.CO;2-C

Source DB:  PubMed          Journal:  Cell Motil Cytoskeleton        ISSN: 0886-1544


  24 in total

1.  The Rab6-binding kinesin, Rab6-KIFL, is required for cytokinesis.

Authors:  E Hill; M Clarke; F A Barr
Journal:  EMBO J       Date:  2000-11-01       Impact factor: 11.598

2.  Functional and physical interactions of the adaptor protein complex AP-4 with ADP-ribosylation factors (ARFs).

Authors:  M Boehm; R C Aguilar; J S Bonifacino
Journal:  EMBO J       Date:  2001-11-15       Impact factor: 11.598

3.  Role of the midbody matrix in cytokinesis: RNAi and genetic rescue analysis of the mammalian motor protein CHO1.

Authors:  Jurgita Matuliene; Ryoko Kuriyama
Journal:  Mol Biol Cell       Date:  2004-04-09       Impact factor: 4.138

Review 4.  Understanding cytokinesis failure.

Authors:  Guillaume Normand; Randall W King
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

Review 5.  Arf GAPs and molecular motors.

Authors:  Ruibai Luo; Christine E Reed; Jeffrey A Sload; Linda Wordeman; Paul A Randazzo; Pei-Wen Chen
Journal:  Small GTPases       Date:  2017-04-21

6.  A family of ADP-ribosylation factor effectors that can alter membrane transport through the trans-Golgi.

Authors:  A L Boman; C j Zhang; X Zhu; R A Kahn
Journal:  Mol Biol Cell       Date:  2000-04       Impact factor: 4.138

7.  Biochemical characterization of purified mammalian ARL13B protein indicates that it is an atypical GTPase and ARL3 guanine nucleotide exchange factor (GEF).

Authors:  Anna A Ivanova; Tamara Caspary; Nicholas T Seyfried; Duc M Duong; Andrew B West; Zhiyong Liu; Richard A Kahn
Journal:  J Biol Chem       Date:  2017-05-09       Impact factor: 5.157

8.  Localization of Pavarotti-KLP in living Drosophila embryos suggests roles in reorganizing the cortical cytoskeleton during the mitotic cycle.

Authors:  Gianluca Minestrini; Alyssa S Harley; David M Glover
Journal:  Mol Biol Cell       Date:  2003-06-27       Impact factor: 4.138

9.  ADP-ribosylation factor (ARF) interaction is not sufficient for yeast GGA protein function or localization.

Authors:  Annette L Boman; Paul D Salo; Melissa J Hauglund; Nicole L Strand; Shelly J Rensink; Olga Zhdankina
Journal:  Mol Biol Cell       Date:  2002-09       Impact factor: 4.138

10.  Arf3 is activated uniquely at the trans-Golgi network by brefeldin A-inhibited guanine nucleotide exchange factors.

Authors:  Florin Manolea; Justin Chun; David W Chen; Ian Clarke; Nathan Summerfeldt; Joel B Dacks; Paul Melançon
Journal:  Mol Biol Cell       Date:  2010-03-31       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.